Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths

Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT™ Admiral™ drug-coated balloon (DCB) in longer, 150 mm lengths. The new 150 mm length balloon, available in four, five, and six mm diameters, will provide greater treatment options for long lesions in patients with peripheral artery disease (PAD).
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news